All In MedTech

Device Trial Radar · NCT02294513

Hearing Instruments in Alzheimer's Disease

Hearing Intervention for Patients With Early-Stage Alzheimer's Disease: Determining the Benefits for Patients and Family Caregivers

Last checked: Nov 19, 2026Latest source record: Apr 11, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Oct 2014

Primary completion

Feb 2017

Study completion Feb 2017

Sponsor

Lead sponsor
Phonak AG, SwitzerlandNot on our public-company list
Sponsor type
Industry
Collaborators
University of Toronto; Baycrest Centre for Geriatric Care
First posted
Nov 19, 2014

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

There is a strong connection between hearing loss and cognitive impairment, particularly dementia, in old age. Worldwide, dementia affects approximately 5% of persons over the age of 65 years. Hearing loss is even more prevalent in old age, affecting an estimated one third of persons over the age of 65 years. Thus, there is likely a large degree of overlap between the impairments. Indeed, this overlap may influence older adults' everyday functioning, communication, social engagement and quality of life, as well as influencing the well-being of their family caregivers. This project will examine whether patients with hearing loss and Alzheimer's disease, the most common form of dementia, derive benefit the from hearing aids prescribed and fit to them following current best practice procedures in a geriatric audiology clinic. For the first time, a formal evaluation of the potential benefits of hearing aids for the patients' family caregivers will also be conducted.

Conditions

  • Alzheimer Disease
  • Hearing Loss

Interventions

  • Standard audiologic rehabilitation (incl. HI)Device

    The intervention consists of standard audiologic rehabilitation in which participants are fit with at least one hearing instrument (HI).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Client Oriented Scale of Improvement (COSI): Change over 3monthsTime frame: 0, 1st, 3rd month (plus 4th and 6th month for controls AD_WaitC & AD_ActC)
  2. Hearing Handicap Inventory of the Elderly (HHIE): Change over 3monthsTime frame: 0, 1st, 3rd month (plus 4th and 6th month for controls AD_WaitC & AD_ActC)
  3. International Outcome Inventory for Hearing Aids (IOI-HA): Change over 2monthsTime frame: 1st, 3rd month for AD_HI & NC_HI (4th, 6th month for controls AD_WaitC & AD_ActC resp.)

4 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Baycrest Center of Geriatric Care

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.